Page 47 - Read Online

Page 12 of 16 Weidner et al. J Transl Genet Genom 2019;3:2. I https://doi.org/10.20517/jtgg.2018.30

have gained insight into particular facets of the disease and its relevance to humans. Recently, several studies
have begun to explore the possibility of miRNAs as biomarkers for asthma, opening the door to a better
understanding of the disease as well as the potential for future therapeutics.

DECLARATIONS
Authors’ contributions
All authors contributed equally to the writing of this manuscript.

Availability of data and materials
Not applicable.

Financial support and sponsorship
This work was supported by grants from Herman Krefting Foundation for Asthma and Allergy research,
the Swedish Heart and Lung Foundation (20170392), Sahlgrenska University Hospital Foundation, KH
Johanssons Foundation and the Swedish Research Council (2017-02302).

Conflicts of interest
All authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2019.

REFERENCES
1. Lambrecht BN, Hammad H. The immunology of asthma. Nat Immunol 2015;16:45-56.
2. GINA. Global strategy for asthma management and prevention. Available from: https://ginasthma.org/wp-content/uploads/2018/04/wms-
GINA-2018-report-tracked_v1.3.pdf. [Last accessed on 27 Dec 2018]
3. Lötvall J, Ekerljung L, Rönmark EP, Wennergren G, Lindén A, et al. West Sweden asthma study: prevalence trends over the last 18 years
argues no recent increase in asthma. Respir Res 2009;10:94.
4. Lundbäck B, Backman H, Lötvall J, Rönmark E. Is asthma prevalence still increasing? Expert Rev Respir Med 2016;10:39-51.
5. Rönmark E, Lundbäck B, Jönsson E, Jonsson AC, Lindström M, et al. Incidence of asthma in adults--report from the obstructive lung
disease in Northern Sweden study. Allergy 1997;52:1071-8.
6. Mincheva R, Ekerljung L, Bossios A, Lundbäck B, Lötvall J. High prevalence of severe asthma in a large random population study. J
Allergy Clin Immunol 2018;141:2256-64.
7. Lötvall J, Akdis CA, Bacharier LB, Bjermer L, Casale TB, et al. Asthma endotypes: a new approach to classification of disease entities
within the asthma syndrome. J Allergy Clin Immunol 2011;127:355-60.
8. Wenzel S. Severe asthma: from characteristics to phenotypes to endotypes. Clin Exp Allergy 2012;42:650-8.
9. Alipoor SD, Adcock IM, Garssen J, Mortaz E, Varahram M, et al. The roles of miRNAs as potential biomarkers in lung diseases. Eur J
Pharmacol 2016;791:395-404.
10. Ameis D, Khoshgoo N, Iwasiow BM, Snarr P, Keijzer R. MicroRNAs in lung development and disease. Paediatr Respir Rev 2017;22:38-43.
11. Booton R, Lindsay MA. Emerging role of MicroRNAs and long noncoding RNAs in respiratory disease. Chest 2014;146:193-204.
12. Peng Y, Croce CM. The role of MicroRNAs in human cancer. Signal Transduct Target Ther 2016;1:15004.
13. Johansson K, Weidner J, Rådinger M. MicroRNAs in type 2 immunity. Cancer Lett 2018;425:116-24.
14. O’Connell RM, Rao DS, Baltimore D. microRNA regulation of inflammatory responses. Annu Rev Immunol 2012;30:295-312.
15. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-97.
16. Ha M, Kim VN. Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol 2014;15:509-24.
17. Bartel DP. Metazoan microRNAs. Cell 2018;173:20-51.